• Alexion to Acquire Achillion for $930M+, Expanding Rare Disease Portfolio

    Alexion Pharmaceuticals has agreed to acquire Achillion Pharmaceuticals for $930 million-plus, the companies said today, in a deal designed to …

    Read More
  • 0 0